Naseem Zojwalla Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

Naseem Zojwalla is Chief Medical Officer of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 4,488 shares of OLMA, which is worth approximately $39,000. The most recent transaction as insider was on Dec 23, 2025, when has been sold 99,509 shares (Common Stock) at a price of $27.66 per share, resulting in proceeds of $2,752,418. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49K

96.53% 3M change

96.53% 12M change

Total Value Held $39,000

Naseem Zojwalla Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2025	SELL Open market or private sale	$2,752,418 $27.66 p/Share	99,509 Reduced 95.68%	4,488 Common Stock
Dec 23 2025	BUY Exercise of conversion of derivative security	$351,000 $7.02 p/Share	50,000 Added 32.47%	103,997 Common Stock
Dec 22 2025	SELL Open market or private sale	$2,804,000 $28.04 p/Share	100,000 Reduced 64.94%	53,997 Common Stock
Dec 22 2025	BUY Exercise of conversion of derivative security	$557,000 $11.14 p/Share	50,000 Added 24.51%	153,997 Common Stock
Dec 19 2025	SELL Open market or private sale	$1,993,600 $28.48 p/Share	70,000 Reduced 40.23%	103,997 Common Stock
Dec 19 2025	BUY Exercise of conversion of derivative security	$610,000 $15.25 p/Share	40,000 Added 18.69%	173,997 Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$68,180 $4.87 p/Share	14,000 Added 9.76%	129,509 Common Stock

Dec 11 2024	SELL Open market or private sale	$131,133 $9.03 p/Share	14,522 Reduced 11.17%	115,509 Common Stock
Dec 10 2024	SELL Open market or private sale	$124,461 $9.37 p/Share	13,283 Reduced 9.27%	130,031 Common Stock
Dec 09 2024	BUY Grant, award, or other acquisition	-	52,000 Added 26.62%	143,314 Common Stock
May 24 2024	BUY Exercise of conversion of derivative security	$46,070 $4.87 p/Share	9,460 Added 9.53%	89,824 Common Stock
Mar 18 2024	BUY Exercise of conversion of derivative security	$66,719 $4.87 p/Share	13,700 Added 14.56%	80,364 Common Stock
Jan 25 2024	BUY Exercise of conversion of derivative security	$140,400 $7.02 p/Share	20,000 Added 23.08%	66,664 Common Stock
Dec 11 2023	BUY Exercise of conversion of derivative security	$20,358 $7.02 p/Share	2,900 Added 5.85%	46,664 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$91,962 $7.02 p/Share	13,100 Added 23.04%	43,764 Common Stock
Nov 22 2023	SELL Open market or private sale	$98,549 $13.89 p/Share	7,095 Reduced 18.79%	30,664 Common Stock
Nov 21 2023	SELL Open market or private sale	$112,511 $15.08 p/Share	7,461 Reduced 16.5%	37,759 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	28,000 Added 38.24%	45,220 Common Stock

Naseem Zojwalla

Chief Medical Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Value

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA

Account